96
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations)

, , , , , & show all
Pages 2121-2129 | Accepted 06 Sep 2006, Published online: 26 Sep 2006

References

  • Diokno A, Burgio K, Fultz NH, et al. Medical and self-care practices reported by women with urinary incontinence. Am J Manage Care 2004;10:69–78
  • Melville JL, Katon W, Delaney K, et al. Urinary incontinence in US women: a population-based study. Arch Intern Med 2005;165:537–42
  • Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Am J Obstet Gynecol 2002;187:116–26
  • Holroyd-Leduc JM, Straus SE. Management of urinary incontinence in women: clinical applications. JAMA 2004;291: 996–9
  • Zinner NR. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence. Expert Opin Investig Drugs 2003;12:1559–66
  • Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003;170: 1259–63
  • Millard RJ, Moore K, Rencken R, et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 2004;93:311–8
  • Norton PA, Zinner NR, Yalcin I, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40–8
  • van Kerrebroeck P, Abrams P, Lange R, et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004;111:249–57
  • Richter HE, Norman AM, Burgio KL, et al. Tension-free vaginal tape: a prospective subjective and objective outcome analysis. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:109–13
  • Holmgren C, Nilsson S, Lanner L, et al. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol 2005;106:38–43
  • Kulkarni PM, Meadows ES, Ahuja S, et al. Rationale for a non-inferiority clinical trial design focused on subpopulations. Curr Med Res Opin 2004;20:1641–7
  • Wyman JF, Choi SC, Harkins SW, et al. The urinary diary in evaluation of incontinent women: a test-retest analysis. Obstet Gynecol 1988;71:812–7
  • Bent AE, Gousse AE, Hendrix SL, et al. Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence. Obstet Gynecol 2005;106:767–73
  • Patrick DL, Martin ML, Bushnell DM, et al. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 1999;53:71–6
  • Patrick DL, Martin ML, Bushnell DM, et al. Cultural adaptation of a quality-of-life measure for urinary incontinence. Eur Urol 1999;36:427–35
  • Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003;189:98–101
  • Grothe KB, Dutton GR, Bodenlos J, et al. Validation of the Beck Depression Inventory – II in a low-income African American sample of medical outpatients. Psychological Assessment 2005;17:110–4
  • Bonilla J, Bernal G, Santos A, et al. A revised Spanish version of the Beck Depression Inventory: psychometric properties with a Puerto Rican sample of college students. J Clin Psychol 2004;60:119–30
  • Cardozo L, Drutz HP, Baygani SK, et al. Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 2004;104:511–9
  • Ghoniem GM, Van Leeuwen JS, Elser DM, et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol 2005;173: 1647–53
  • DuBeau CE, Khullar V, Versi E. ‘Unblinding’ in randomized controlled drug trials for urinary incontinence: implications for assessing outcomes when adverse effects are evident. Neurourol Urodyn 2005;24:13–20
  • Hurley DJ, Turner CL, Yalcin I, et al. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety. Eur J Obstet Gynecol Reprod Biol 2006;125:120–8
  • Powell JH, Fleming Y. Making medicines for America: the case for clinical trial diversity. J Natl Med Assoc 2000;92:507–14
  • Burroughs VJ, Maxey RW, Levy RA. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc 2002;94:1–26
  • Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170–5
  • Howard D, Delancey JO, Tunn R, et al. Racial differences in the structure and function of the stress urinary continence mechanism. Obstet Gynecol 2000;95:713–7
  • Duong TH, Korn AP. A comparison of urinary incontinence among African American, Asian, Hispanic, and white women. Am J Obstet Gynecol 2001;184:1083–6
  • Kubik K, Blackwell L, Heit M. Does socioeconomic status explain racial differences in urinary incontinence knowledge? Am J Obstet Gynecol 2004;192:188–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.